The Environment of the Lipoxygenase Iron Binding Site Explored with Novel Hydroxypyridinone Iron Chelators

Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects

Samuelsson, B. O., Dahlén, S., LINDGREN, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233 · see citing works

Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1

Abo, A., Pick, E., Hall, A., Totty, N. F., Teahan, C. G., & Segal, A. W. (1991) · Nature · doi:10.1038/353668a0 · Cited by 954 · see citing works

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

Dixon, R. A. F., Diehl, R. E., Opas, E. E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W., & Miller, D. K. (1990) · Nature · doi:10.1038/343282a0 · Cited by 772 · see citing works

Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases

Borgeat, P., Hámberg, M., & Samuelsson, B. O. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57008-9 · Cited by 643 · see citing works

The Three-Dimensional Structure of an Arachidonic Acid 15-Lipoxygenase

Boyington, J. C., Gaffney, B. J., & Amzel, L. M. (1993) · Science · doi:10.1126/science.8502991 · Cited by 468 · see citing works

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.

Woods, J. W., Evans, J. F., Ethier, D., Scott, S., Vickers, P. J., Hearn, L., Heibein, J. A., Charleson, S. E., & Singer, I. I. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.1935 · Cited by 392 · see citing works

5-LIPOXYGENASE

Ford‐Hutchinson, A. W., Gresser, M. J., & Young, R. N. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002123 · Cited by 365 · see citing works

Primary structure of soybean lipoxygenase L-2.

Shibata, D., Steczko, J., Dixon, J. E., Andrews, P., Hermodson, M. A., & Axelrod, B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68716-2 · Cited by 239 · see citing works

Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential

Dobbin, P. S., Hider, R. C., Hall, A. D., Taylor, P. D., Sarpong, P., Porter, J. B., Xiao, G., & der Helm, D. V. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00069a002 · Cited by 217 · see citing works

cis-Polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils.

Badwey, J. A., Curnutte, J. T., & Karnovsky, M. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42939-0 · Cited by 209 · see citing works

Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells.

Brock, T. G., Paine, R., & Peters-Golden, M. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31755-6 · Cited by 152 · see citing works

Prostaglandins and related substances: A practical approach

Hoult, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80151-0 · Cited by 150 · see citing works

Designing therapeutically effective 5-lipoxygenase inhibitors

McMillan, R. M., & Walker, E. R. H. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90100-k · Cited by 146 · see citing works

Human 5-lipoxygenase contains an essential iron

Percival, M. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99187-8 · Cited by 137 · see citing works

Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties and biological activity

Streater, M., Taylor, P. D., Hider, R. C., & Porter, J. B. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00168a033 · Cited by 115 · see citing works

Prostaglandins, Leukotrienes and lipoxins

Williams, K. I. H. (1986) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(86)90332-9 · Cited by 111 · see citing works

The Dioxygenation Rate In Lipoxygenase Catalysis Is Determined by the Amount of Iron(III) Lipoxygenase in Solution

Schilstra, M. J., Veldink, G. A., & Vliegenthart, J. F. G. (1994) · Biochemistry · doi:10.1021/bi00179a025 · Cited by 99 · see citing works

5‐Lipoxygenase and 12‐Lipoxygenase: Attractive Targets for the Development of Novel Antipsoriatic Drugs. 5‐Lipoxygenase und 12‐Lipoxygenase: Attraktive Target‐Enzyme für die Entwicklung neuer Antipsoriatika

Müller, K. M. (1994) · Archiv der Pharmazie · doi:10.1002/ardp.19943270103 · Cited by 92 · see citing works

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.

Evans, J. F., Lévillé, C., Mancini, J. A., Prasit, P., Thérien, M., Zamboni, R. J., GAUTHIER, J. Y., Fortin, R., Charleson, P., & MacIntyre, D. E. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12843-5 · Cited by 76 · see citing works

2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity

Batt, D. G., Maynard, G. D., Petraitis, J. J., Shaw, J. E., Galbraith, W., & Harris, R. R. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00163a058 · Cited by 70 · see citing works

Site-directed mutagenesis studies on the iron-binding domain and the determinant for the substrate oxygenation site of porcine leukocyte arachidonate 12-lipoxygenase

Suzuki, H., Kishimoto, K., Yoshimoto, T., Yamamoto, S., Kanai, F., Ebina, Y., Miyatake, A., & Tanabe, T. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90234-8 · Cited by 69 · see citing works

In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase

Summers, J. B., Gunn, B. P., Mazdiyasni, H., Goetze, A. M., Young, P. R., Bouska, J. B., Dyer, R. D., Brooks, D. W., & Carter, G. W. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00394a032 · Cited by 64 · see citing works

Reduction of the active-site iron by potent inhibitors of lipoxygenases

Nelson, M. J., Batt, D. G., Thompson, J. S., & Wright, S. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92965-0 · Cited by 60 · see citing works

Evaluation of the role of conserved His and Met residues among lipoxygenases by site-directed mutagenesis of recombinant human 5-lipoxygenase.

Nguyen, T. M., Falgueyret, J., Abramovitz, M., & Riendeau, D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54744-x · Cited by 58 · see citing works

Iron content of human 5-lipoxygenase, effects of mutations regarding conserved histidine residues.

Zhang, Y. Y., Lind, B., Rådmark, O., & Samuelsson, B. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53808-4 · Cited by 57 · see citing works

Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity

Barradas, M. A., Jeremy, J. Y., Kontoghiorghes, G. J., Mikhailidis, D. P., Hoffbrand, A. V., & Dandona, P. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80201-7 · Cited by 55 · see citing works

On the spin and valence state of iron in native soybean lipoxygenase-1

Slappendel, S., Malmström, B. G., Petersson, L., Ehrenberg, A., Veldink, G. A., & Vliegenthart, J. F. G. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)90882-8 · Cited by 51 · see citing works

Magnetic susceptibility studies on yellow and anaerobically substrate-treated yellow soybean lipoxygenase-1

Petersson, L., Slappendel, S., Feiters, M. C., & Vliegenthart, J. F. G. (1987) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(87)90334-7 · Cited by 45 · see citing works

Microcomputer application of non-linear regression analysis to metal-ligand equilibria

Taylor, P. D. (1988) · Talanta · doi:10.1016/0039-9140(88)80123-1 · Cited by 42 · see citing works

Effect of 6,9-deepoxy-6,9-(phenylimino)-Δ 6,8-prostaglandin 11 (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function

Smith, R. J., Sun, F. F., Bowman, B. J., Iden, S. S., Smith, H. W., & McGuire, J. C. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)92031-9 · Cited by 39 · see citing works

2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis

Hammond, M. L., Kopka, I. E., Zambias, R. A., Caldwell, C. G., Boger, J., Baker, F., Bach, T., Luell, S., & MacIntyre, D. E. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00125a014 · Cited by 37 · see citing works

Erratum

Ishii, S., Noguchi, M., Miyano, M., Matsumoto, T., & Noma, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90710-3 · Cited by 36 · see citing works

Quantitative Structure-Activity Relationship of Catechol Derivatives Inhibiting 5-Lipoxygenase.

NAITO, Y., SUGIURA, M., YAMAURA, Y., Fukaya, C., YOKOYAMA, K., Nakagawa, Y., Ikeda, T., Senda, M., & Fujita, T. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.1736 · Cited by 33 · see citing works

Mutagenesis studies on the amino acid residues involved in the iron-binding and the activity of human 5-lipoxygenase

Ishii, S., Noguchi, M., Miyano, M., Matsumoto, T., & Noma, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91901-2 · Cited by 33 · see citing works

FcγRII-Mediated Superoxide Production by Phagocytes Is Augmented by GM-CSF Without a Change in FCγRII Expression

Roberts, P. J., Devereux, S., Pilkington, G. R., & Linch, D. C. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.48.3.247 · Cited by 32 · see citing works

The regulation of neutrophil phospholipase A2 by granulocyte‐macrophage colony‐stimulating factor and its role in priming superoxide production

Roberts, P. J., Williams, S. L., & Linch, D. C. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.432970.x · Cited by 18 · see citing works

Patent Update: Inhibitors of the Phospholipases A2

Connolly, S., & ROBINSON, D. H. (1993) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.3.8.1141 · Cited by 17 · see citing works

The effect of inhibition of leukotriene synthesis on the activity of interleukin‐8 and granulocyte‐macrophage colony‐stimulating factor

Roberts, P. J., Pizzey, A. R., & Linch, D. C. (1993) · Mediators of Inflammation · doi:10.1155/s0962935193000286 · Cited by 4 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

The role of iron and reactive oxygen species in cell death

Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381 · see citing works

Mechanisms of ferroptosis

Cao, J. Y., & Dixon, S. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2194-1 · Cited by 1,515 · see citing works

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T., & Liddell, J. R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00466 · Cited by 421 · see citing works

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411 · see citing works

Ferroptosis: bug or feature?

Dixon, S. J. (2017) · Immunological Reviews · doi:10.1111/imr.12533 · Cited by 314 · see citing works

Design of iron chelators with therapeutic application

Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00050-4 · Cited by 287 · see citing works

Design of clinically useful iron(III)‐selective chelators

Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266 · see citing works

Secondary Iron Overload

Kushner, J. P., Porter, J. B., & Olivieri, N. F. (2001) · Hematology · doi:10.1182/asheducation-2001.1.47 · Cited by 246 · see citing works

Metals ions and neurodegeneration

Molina‐Holgado, F., Hider, R. C., Gaeta, A., Williams, R., & Francis, P. T. (2007) · BioMetals · doi:10.1007/s10534-006-9033-z · Cited by 207 · see citing works

Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders

Wu, J., Tuo, Q., & Lei, P. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1155-6 · Cited by 184 · see citing works

Iron chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity

Chaston, T. B., & Richardson, D. R. (2003) · American Journal of Hematology · doi:10.1002/ajh.10348 · Cited by 168 · see citing works

Iron, ferroptosis, and ischemic stroke

Guo, J., Tuo, Q., & Lei, P. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15807 · Cited by 161 · see citing works

The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151 · see citing works

Iron overload: Effects on cellular biochemistry

Nogueira, L. S., Oliveira, M. M., Pessoa, M. T., & Barbosa, L. A. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.029 · Cited by 144 · see citing works

Design of iron chelators with therapeutic application

Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136 · see citing works

The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro

Clément, P. M., Hanauske-Abel, H. M., Wolff, E. C., Kleinman, H. K., & Park, M. H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10515 · Cited by 128 · see citing works

A Risk-Benefit Assessment of Iron-Chelation Therapy

Porter, J. B. (1997) · Drug Safety · doi:10.2165/00002018-199717060-00006 · Cited by 95 · see citing works

Renal complications in transfusion-dependent beta thalassaemia

Ponticelli, C. E., Musallam, K. M., Cianciulli, P., & Cappellini, M. D. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.08.004 · Cited by 93 · see citing works

Advances in iron chelation: an update

Heli, H., Mirtorabi, S., & Karimian, K. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.569493 · Cited by 92 · see citing works

A New Role for Old Ligands: Discerning Chelators for Zinc Metalloproteinases

Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057957s · Cited by 82 · see citing works

Ferroptosis and endoplasmic reticulum stress in ischemic stroke

Li, Y., Li, M., Feng, S., Xu, Q., Zhang, X. D., Xiong, X., & Gu, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380870 · Cited by 82 · see citing works

Iron: Effect of Overload and Deficiency

Hider, R. C., & Kong, X. (2013) · Metal ions in life sciences · doi:10.1007/978-94-007-7500-8_8 · Cited by 74 · see citing works

Design, Synthesis, and Evaluation of Novel 2-Substituted 3-Hydroxypyridin-4-ones: Structure−Activity Investigation of Metalloenzyme Inhibition by Iron Chelators

Liu, Z. D., Kayyali, R., Hider, R. C., Porter, J. B., & Theobald, A. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010817i · Cited by 70 · see citing works

Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents

Curnow, A., Mcllroy, B., Postle-Hacon, M., Porter, J., MacRobert, A., & Bown, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.671 · Cited by 68 · see citing works

Cellular zinc content is a major determinant of iron chelator–induced apoptosis of thymocytes

Maclean, K. H., Cleveland, J. L., & Porter, J. B. (2001) · Blood · doi:10.1182/blood.v98.13.3831 · Cited by 52 · see citing works

Fe(III) Oxide Reduction by a Gram-positive Thermophile: Physiological Mechanisms for Dissimilatory Reduction of Poorly Crystalline Fe(III) Oxide by a Thermophilic Gram-positive BacteriumCarboxydothermus ferrireducens

Gavrilov, S. N., Lloyd, J. R., Kostrikina, N. A., & Slobodkin, A. I. (2012) · Geomicrobiology Journal · doi:10.1080/01490451.2011.635755 · Cited by 49 · see citing works

Hydroxypyranones, hydroxypyridinones, and their complexes

Burgess, J. R., & Rangel, M. (2008) · Advances in inorganic chemistry · doi:10.1016/s0898-8838(08)00005-6 · Cited by 48 · see citing works

Comparative Radical Scavenging Ability of Bidentate Iron(III) Chelators

Kayyali, R., Pannala, A. S., Khodr, H., & Hider, R. C. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00602-3 · Cited by 46 · see citing works

Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities

Abbasi, U., Abbina, S., Gill, A., Takuechi, L. E., & Kizhakkedathu, J. N. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00122 · Cited by 47 · see citing works

Synthesis, physical–chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer’s disease

Gaeta, A., Molina‐Holgado, F., Kong, X. L., Salvage, S., Fakih, S., Francis, P. T., Williams, R. J., & Hider, R. C. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.007 · Cited by 45 · see citing works

Inhibition of β-carotene-15,15′-dioxygenase activity by dietary flavonoids

Nagao, A., Maeda, M., Lim, B. P., Kobayashi, H., & Terao, J. (2000) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(00)00090-5 · Cited by 44 · see citing works

The gills as an important uptake route for the essential nutrient iron in freshwater rainbow trout Oncorhynchus mykiss

Cooper, C. A., & Bury, N. R. (2007) · Journal of Fish Biology · doi:10.1111/j.1095-8649.2007.01474.x · Cited by 38 · see citing works

Structure-Function Investigation of the Interaction of 1- and 2-Substituted 3-Hydroxypyridin-4-ones with 5-Lipoxygenase and Ribonucleotide Reductase

Kayyali, R., Porter, J. B., Liu, Z. D., Davies, N. A., Nugent, J. H. A., Cooper, C. E., & Hider, R. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109551200 · Cited by 38 · see citing works

Results of Long Term Iron Chelation Treatment with Deferoxamine

Davis, B. A., & Porter, J. B. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0593-8_6 · Cited by 36 · see citing works

Oral iron chelators – development and application

Liu, D. Y., Liu, Z. D., & Hider, R. C. (2002) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(02)90209-4 · Cited by 36 · see citing works

Affecting the activity of soybean lipoxygenase-1

Wu, H. (1996) · Journal of Molecular Graphics · doi:10.1016/s0263-7855(97)00006-4 · Cited by 35 · see citing works

Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid

Curnow, A., MacRobert, A. J., & Bown, S. G. (2006) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20328 · Cited by 34 · see citing works

Metal attenuating therapies in neurodegenerative disease

Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 31 · see citing works

Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy

Ld, D., Evans, R. W., Evans, P., & Hider, R. C. (2007) · Biochemical Journal · doi:10.1042/bj20070823 · Cited by 28 · see citing works

4-Hydroxy tempol-induced impairment of mitochondrial function and augmentation of glucose transport in vascular endothelial and smooth muscle cells

Alpert, E., Altman, H., Totary-Jain, H., Gruzman, A., Barnea, D., Barash, V., & Sasson, S. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.005 · Cited by 26 · see citing works

Effect of metal ions on the production of isomeric 9,10,13 (9,12,13)-trihydroxy-11E (10E)-octadecenoic acid from linoleic acid by Pseudomonas aeruginosa PR3

Kim, H., Jang, Y., & HOU, C. T. (2002) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(02)00053-4 · Cited by 23 · see citing works

Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses

Zhang, C., Yu, J., Yang, C., Shang, S., Lv, X., Cui, B., & Hua, F. (2022) · Cancer Innovation · doi:10.1002/cai2.7 · Cited by 21 · see citing works

Structure–activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase

Liu, Z. D., Lockwood, M., Rose, S., Theobald, A. E., & Hider, R. C. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00551-7 · Cited by 22 · see citing works

Anticancer activity of a novel methylated analogue of L-mimosine against an in vitro model of human malignant melanoma

Kyriakou, S., Mitsiogianni, M., Mantso, T., Cheung, W., Todryk, S. M., Veuger, S. J., Pappa, A., Tétard, D., & Panayiotidis, M. I. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00809-0 · Cited by 20 · see citing works

Iron Chelator Chemistry

Liu, Z. D., Liu, D. Y., & Hider, R. C. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0593-8_8 · Cited by 15 · see citing works

Vanadium(V) complexes with hydrazides and their spectroscopic and biological properties

Sultan, S., Ashiq, U., Jamal, R. A., Mahroof‐Tahir, M., Shaikh, Z., Shamshad, B., Lateef, M., & Iqbal, L. (2017) · BioMetals · doi:10.1007/s10534-017-0054-6 · Cited by 13 · see citing works

A study on the anti-inflammatory effects of new derivatives of 3-hydroxy pyridine-4-one

Hajhashemi, V., Mojiri-Froshani, H., Saghaei, L., & Fassihi, A. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.133276 · Cited by 10 · see citing works

Iron

TWIGG, M. V., & Burgess, J. R. (2003) · Elsevier eBooks · doi:10.1016/b0-08-043748-6/04208-0 · Cited by 9 · see citing works

Invetigation into the Mechanism of Action and Effects of Triticum Aestivum (Wheat) Grass

Desai, T. R. (2005) · Cited by 9 · see citing works

6-Alkoxymethyl-3-hydroxy-4H-pyranones: potential ligands for cell-labelling with indium

Ellis, B. L., Sampson, C. B., Abeysinghe, R. D., Porter, J. B., & Hider, R. C. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050471 · Cited by 7 · see citing works

Quantitative-Structure Activity Relationships on Lipoxygenase Inhibitors #

Press, B., Hadjipavlou‐Litina, D., & Pontiki, E. A. (2002) · Cited by 7 · see citing works

A study on the analgesic effects of four new derivatives of 3-hydroxy pyridine-4-one.

Hajhashemi, V., Saghaei, L., Fassihi, A., & Mojiri-Froshani, H. (2012) · Europe PMC (PubMed Central) · Cited by 6 · see citing works

Lipoxygenase Inhibitory Activity of 6-Pentadecanylsalicylic Acid without Prooxidant Effect

Kubo, I., Ha, T. J., & Shimizu, K. (2010) · Natural Product Communications · doi:10.1177/1934578x1000500121 · Cited by 5 · see citing works

Complementary regulatory mechanisms of Fe(II) and Fe(III) on anammox bacteria under low ammonium stress

Gao, B., Zhang, X., Zhang, X., Al-Dhabi, N. A., Tang, W., Jin, D., & Wu, P. (2025) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2025.118949 · Cited by 4 · see citing works

When Pathways Converge: Iron, Lipid Peroxidation, and α‐Synuclein in Ferroptosis‐Driven Dopaminergic Neurodegeneration

Sperlich, C. L., Stockwell, B. R., & Farina, M. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70438 · Cited by 5 · see citing works

Enzymatic Oxidants, Antioxidants, and Inflammatory Bowel Disease

Esworthy, R. S. (2025) · Applied Biosciences · doi:10.3390/applbiosci4020019 · Cited by 5 · see citing works

Transfusion and Iron Chelation Therapy in Thalassemia and Sickle Cell Disease

Kwiatkowski, J. L., & Porter, J. B. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.040 · Cited by 4 · see citing works

Synthesis, analysis and cytotoxic evaluation of some hydroxypyridinone derivatives on HeLa and K562 cell lines.

Saghaie, L., Sadeghi‐Aliabadi, H., & Ashaehshoar, M. (2013) · Europe PMC (PubMed Central) · Cited by 4 · see citing works

Role of Lipoxygenase in the Regulation of Glucose Transport in Aortic Vascular Cells

Sasson, S., Davarashvili, A., & Reich, R. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_55 · Cited by 3 · see citing works

Basic Principles of Metal Chelation and Chelator Design

Hider, R. C., & Ma, Y. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623892-00024 · Cited by 3 · see citing works

A Mechanistic Discussion on Oxidative Stress and FerroptosisPreprint

Mukherjee, S., & Munshi, C. (2023) · Preprints.org · doi:10.20944/preprints202310.1423.v1 · Cited by 1 · see citing works

Unveiling melatonin’s multifaceted actions against ferroptotic neurotoxicity in ischemic stroke

Boonmag, S., Reiter, R. J., & Govitrapong, P. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102219 · Cited by 1 · see citing works

Comments on Contemporary Methods of Oxygen and Nitrogen Free Radical Detection

(2005) · CRC Press eBooks · doi:10.1201/9781420030853.pt3 · Cited by 1 · see citing works

HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation

Tewari, D., Lloyd-Jones, K., Hider, R. C., & Collins, H. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.342 · Cited by 1 · see citing works

A Proof for Substitution of Endogenous Iron (II) in Lipoxygenase by Exogenous Cu2+

Cai, Y., Xu, H. L., Xia, Y., Su, Y.-F., & Fang, Y. (2009) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-009-8876-5

The design of low toxicity 3-hydroxy-pyridin-4-one iron chelators

Kayyali, R., Porter, J. B., & Hider, R. C. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb02461.x

NEW APPROACHES TO THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIA

Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.039

Iron chelators reduce prostaglandins and leukotrienes by inhibiting cyclooxygenase and lipoxygenase: A hypothesis to attenuate PPARγ transcriptional activity in prostate cancer

Noulsri, E., & Lerdwana, S. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.111895

Interaction of diosmetin, diosmin and diosmetin-7-O-glucoside with human erythrocytes, their model membrane, hemoglobin and redox-active metal ions

Kaźmierczak, T., Lomozová, Z., Mladěnka, P., Gąsior‐Głogowska, M., Bonarska‐Kujawa, D., & Cyboran-Mikołajczyk, S. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1814932

Design, Synthesis, and Evaluation of Novel 2-Substituted 3-Hydroxypyridin-4-ones: Structure−Activity Investigation of Metalloenzyme Inhibition by Iron Chelators

Liu, Z. D., Kayyali, R., Hider, R. C., Porter, J. B., & Theobald, A. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010817i · Cited by 70 · see citing works

Structure-Function Investigation of the Interaction of 1- and 2-Substituted 3-Hydroxypyridin-4-ones with 5-Lipoxygenase and Ribonucleotide Reductase

Kayyali, R., Porter, J. B., Liu, Z. D., Davies, N. A., Nugent, J. H. A., Cooper, C. E., & Hider, R. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109551200 · Cited by 38 · see citing works

Structure–activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase

Liu, Z. D., Lockwood, M., Rose, S., Theobald, A. E., & Hider, R. C. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00551-7 · Cited by 22 · see citing works

Role of ferric iron in platelet lipoxygenase activity

Greenwald, J. E., Alexander, M. S., Fertel, R. H., Beach, C. A., Wong, L. K., & Bianchine, J. R. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91428-x · Cited by 16 · see citing works

Lipoxygenases from soybeans and rabbit reticulocytes: inactivation and iron release.

Höhne, W. E., Kojima, N., Thiele, B. J., & Sm, R. (1991) · PubMed · Cited by 2 · see citing works